Solving the big problem of measuring tiny nanoparticles

Tiny nanoparticles play a gargantuan role in modern life, even if most consumers are unaware of their presence. They provide essential ingredients in sunscreen lotions, prevent athlete’s foot fungus in socks, and fight microbes on bandages. They enhance the colors…

New proteomics technique gives insights into ubiquitin signalling

Australian researchers are among the first in the world to have access to a new approach to understand intricate changes that control how proteins function in our cells in health and disease. The new proteomics technique called ‘ubiquitin clipping’ allows…

Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies

Boehringer Ingelheim and MD Anderson have announced a new multi-year partnership to conduct collaborative research, combining the drug-development capabilities of MD Anderson with the pipeline of novel medicines from Boehringer Ingelheim.

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.

Heather J. Lynch, PhD

Blavatnik Awards for Young Scientists Announces 2019 National Laureates

An ecologist from Stony Brook University, a theoretical physicist from University of Colorado Boulder and a chemical biologist from Harvard University Three female scientists have been named Laureates of the Blavatnik National Awards for Young Scientists, each receiving $250,000, the…

SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts

LOS ANGELES and HEIDELBERG, Germany, June 21, 2019 /PRNewswire/ — SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics and radiotherapeutics (“theranostics”) that are…

Leading Health and Technology Organizations Release Common Cancer Data Standards to Enable Sharing Across EHR Systems and Improve Patient Care

Chicago – In an effort to advance cancer data sharing and improve the quality and coordination of patient care, three of the nation’s leading health organizations have established a core set of data elements and recommended technical specifications (the Minimal…